Clinical Trial Update: Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating applicability of PDOX in patients with resectable hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhujiang Hospital | Conditions: Hepatocellular Carcinoma Resectable | Phase 3 | Status: UNKNOWN